Sleep

When CPAP Uncovers a Second Kind of Apnea

Save

Starting CPAP is supposed to fix breathing pauses, not reveal a new kind. When it does, the finding has a name, a known mechanism, and a follow-up path — and for many people it settles with continued therapy rather than requiring a different machine.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What is complex sleep apnea?

Complex sleep apnea — also called treatment-emergent central sleep apnea, or CompSAS — describes a specific and fairly narrow situation: someone is diagnosed with ordinary obstructive sleep apnea, starts CPAP or a similar pressure-based therapy, and a follow-up recording shows new central apnea events, breathing pauses with no effort at all, that were minimal or absent on the original diagnostic study. It is not a separate disease so much as a pattern that becomes visible once the obstructive piece of the problem is being treated.

It is uncommon relative to garden-variety obstructive apnea, and it is found, not guessed at: the diagnosis depends on a recording, either during in-lab titration or a follow-up study, that directly compares breathing effort before and after pressure therapy started. Anyone arriving here without a baseline sense of what is sleep apnea more generally will find this pattern easier to place once the underlying difference between an obstructed airway and a stalled breathing signal is clear.

Why starting CPAP can uncover it, rather than cause it

The leading explanation is not that CPAP creates a new problem, but that it unmasks one that was already present in a milder or less visible form. Some people have breathing control that sits close to an unstable threshold — small swings in blood carbon dioxide levels are enough to briefly shut off the drive to breathe — and while an obstructed airway was the dominant event on the diagnostic study, opening that airway with pressure can let the underlying instability show up as central pauses instead.

That framing matters for how the finding gets talked about with a patient: it is a sign that a specific and recognized breathing-control pattern is present, not a sign that CPAP has failed or made things worse. The airway is doing exactly what it is supposed to do; a second, separate mechanism is what remains to be addressed.

How it gets found, and why a repeat study beats guesswork

Most people encounter this finding either during an attended in-lab titration study, where a technologist is watching breathing effort in real time as pressure is adjusted, or on a follow-up recording ordered because symptoms haven't improved the way they should have. Guidance on the longitudinal management of obstructive sleep apnea supports exactly this approach: when therapy response is uncertain, repeating a sleep study is the recommended way to find out what's actually happening, rather than assuming a pressure tweak alone will fix persistent symptoms 1.

A simple home sleep apnea test is generally not the tool for this question. Home devices are built and validated around detecting obstruction in otherwise straightforward cases, and distinguishing a true central event from ordinary data noise usually needs the fuller effort-and-airflow picture that an attended study provides.

Does it go away on its own?

For a meaningful share of people, yes — continuing with PAP therapy as prescribed allows the pattern to settle over the following weeks as the underlying breathing-control instability stabilizes, without ever needing a different machine. a new central-apnea finding during CPAP titration is not, by itself, a reason to panic or assume therapy is failing. For others, the pattern persists despite continued, correctly-fitted use, and that is the group a sleep specialist will typically want to reassess directly rather than manage by trial and error at home.

Either way, stopping therapy altogether is rarely the right response to this finding. The guideline evidence behind positive airway pressure's core benefits — reduced sleepiness and improved quality of life for adults with obstructive sleep apnea — was not built on flawless overnight recordings free of any central events, and abandoning treatment removes the benefit that is well established while doing nothing to address the newer, less common finding 2. It is a different question from whether does sleep apnea ever go away in the broader sense — that is mostly a conversation about the original obstructive diagnosis and weight or anatomy, not about this treatment-related finding.

What happens when it doesn't resolve

When central events persist despite adequate time on standard CPAP, the next step is usually a different kind of pressure device, more sophisticated than a single fixed setting, chosen and titrated by a sleep specialist rather than swapped in at home. This is one of the specific, clinically grounded reasons someone might move from CPAP toward a bilevel device — the same two-pressure mechanism used more broadly for people who need help with the breath itself, not just an open airway.

Oral appliance therapy and other non-PAP options, which work by repositioning the jaw and tongue rather than pressurizing the airway, are guideline-recommended alternatives for people who cannot tolerate any PAP-based approach 3, though they address the obstructive component and are not typically the answer for a predominantly central pattern on their own. A broader look at evidence-ranked cpap alternatives is useful context for the obstructive side of the picture, even though most of those options were not studied specifically in people with a treatment-emergent central pattern.

Does this finding change what PAP therapy has actually been proven to do?

Not for the core, well-documented benefits. In a large randomized trial of people with moderate-to-severe obstructive sleep apnea and existing heart disease, CPAP reduced snoring and daytime sleepiness and improved mood and quality of life, without proving a reduction in heart attacks or strokes on its own 4. That evidence describes standard OSA therapy broadly and is a useful, honest baseline for what any pressure-based device, including one adjusted for a treatment-emergent central pattern, can be expected to deliver.

Separately, observational research has tied untreated severe sleep-disordered breathing to substantially higher long-term cardiovascular and mortality risk compared with treated disease 5 — the same broad body of concern that shows up in sleep apnea and stroke risk and sleep apnea and erectile dysfunction discussions, and one more reason persistent symptoms after a treatment-emergent finding deserve a specialist follow-up rather than quietly giving up on therapy altogether. A recurring morning headache is one of the more common complaints people raise at that follow-up, and apnea morning headaches are worth mentioning specifically, since they can persist through a treatment-emergent period even as other symptoms improve.

Questions worth asking a sleep specialist about this finding

Anyone told they have a treatment-emergent central pattern can reasonably ask exactly how it was measured (an attended titration versus a home device), how many events were seen and over what portion of the night, and what the plan is if it hasn't resolved by the next follow-up. Those specifics change the answer far more than the label "complex sleep apnea" does on its own.

It's also worth asking directly whether continuing the current device while the pattern is monitored is reasonable, or whether a change is being recommended now, and why. A clear, specific answer to that question is a reasonable thing to expect before agreeing to a new device or a change in therapy.

Common questions

They overlap but are not identical. Central sleep apnea can occur on its own, often tied to heart failure, opioid use, or altitude. Complex sleep apnea specifically refers to central events that appear or persist once obstructive sleep apnea is being treated with positive airway pressure — a narrower, treatment-related situation rather than a stand-alone central-apnea diagnosis.

It is uncommon relative to straightforward obstructive sleep apnea, and estimates vary depending on how it's defined and measured, which is part of why a direct conversation with the sleep team that read the study is more useful than a general number. What matters clinically is whether it's found and how it's tracked, not how rare it is in the abstract.

Generally not on their own initiative. The finding is a reason to loop in the sleep team for reassessment, not a reason to discontinue a therapy with well-documented benefits for sleepiness and quality of life. Any decision to pause or change therapy should come from that follow-up conversation.

Not necessarily. For many people the pattern eases as breathing control stabilizes over continued use, and no permanent equipment change is needed. For others it persists and a bilevel or more advanced pressure device becomes the long-term therapy; which group someone falls into is determined by follow-up testing, not by how the initial finding looked.

It is described almost entirely in the context of pressure-based therapy, since oral appliances work by a completely different mechanism — repositioning the jaw and tongue rather than pressurizing the airway — and don't create the same conditions under which this pattern has been observed.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When to involve a sleep specialist rather than wait it out

  • —daytime sleepiness or gasping arousals that continue or worsen despite consistent, correctly-fitted PAP use
  • —chest pain, palpitations, or worsening shortness of breath, especially with a history of heart failure
  • —new confusion, marked leg swelling, or a persistent sense of air hunger alongside apnea symptoms

Chest pain, palpitations, or significant new shortness of breath — especially with a heart-failure history — warrants emergency evaluation, 911 or the nearest emergency department, not a wait for a routine sleep-clinic follow-up.

This article explains what complex, or treatment-emergent, sleep apnea is in general terms; it does not diagnose it or recommend a specific device or treatment change. Any finding on a sleep study should be reviewed with the ordering clinician or sleep specialist.

References

  1. 1.Chang JL, Goldberg AN, Alt JA, et al. (2021). Use of polysomnography and home sleep apnea tests for the longitudinal management of obstructive sleep apnea in adults: an American Academy of Sleep Medicine clinical guidance statement. Journal of Clinical Sleep Medicine. doi:10.5664/jcsm.9240 ✓That repeating a sleep study is the guideline-supported way to reassess uncertain therapy response, rather than adjusting settings by guesswork.
  2. 2.Patil SP, Ayappa IA, Caples SM, Kimoff RJ, Patel SR, Harrod CG (2019). Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine. doi:10.5664/jcsm.7640 ✓That positive airway pressure therapy is recommended first-line for adults with OSA to reduce sleepiness and improve quality of life.
  3. 3.Ramar K, Dort LC, Katz SG, Lettieri CJ, Harrod CG, Thomas SM, Chervin RD (2015). Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015. Journal of Clinical Sleep Medicine (AASM/AADSM). doi:10.5664/jcsm.4858 ✓That a custom oral appliance is a guideline-recommended alternative for adults with OSA who cannot tolerate CPAP or prefer another option.
  4. 4.McEvoy RD, Antic NA, Heeley E, et al. (SAVE Investigators) (2016). CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. New England Journal of Medicine. doi:10.1056/NEJMoa1606599 ✓That in a randomized trial of people with moderate-to-severe OSA and cardiovascular disease, CPAP reduced snoring and sleepiness and improved mood and quality of life, without proving a reduction in cardiovascular events.
  5. 5.Marin JM, Carrizo SJ, Vicente E, Agusti AGN (2005). Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. The Lancet. doi:10.1016/S0140-6736(05)71141-7 ✓That untreated severe OSA is associated with substantially higher cardiovascular and mortality risk than treated OSA in observational cohort data.

5 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library